Literature DB >> 25125564

Urea cycle disorders: a life-threatening yet treatable cause of metabolic encephalopathy in adults.

Nicholas F Blair1, Philip D Cremer1, Michel C Tchan2.   

Abstract

Urea cycle disorders are inborn errors of metabolism that, in rare cases, can present for the first time in adulthood. We report a perplexing presentation in a woman 4 days postpartum of bizarre and out-of-character behaviour interspersed with periods of complete normality. Without any focal neurological signs or abnormality on initial investigations, the diagnosis became clear with the finding of a significantly elevated plasma ammonia level, just as she began to deteriorate rapidly. She improved following intravenous dextrose and lipid emulsion, together with sodium benzoate, arginine and a protein-restricted diet. She remains well 12 months later with no permanent sequelae. Whilst this is a rare presentation of an uncommon disease, it is a treatable disorder and its early diagnosis can prevent a fatal outcome. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Encephalopathies, Metabolic; Hyperammonemia; Ornithine Carbamoyltransferase Deficiency Disease; Postpartum Period; Urea Cycle Disorders, Inborn

Mesh:

Substances:

Year:  2014        PMID: 25125564     DOI: 10.1136/practneurol-2014-000916

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  7 in total

1.  Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma.

Authors:  Alessandra Gaiani; Sara Pompanin; Renato Zambello; Chiara Briani; Annachiara Cagnin
Journal:  Neurol Sci       Date:  2016-10-07       Impact factor: 3.307

2.  Hyperammonemia due to Adult-Onset N-Acetylglutamate Synthase Deficiency.

Authors:  Anne-Els van de Logt; Leo A J Kluijtmans; Marleen C D G Huigen; Mirian C H Janssen
Journal:  JIMD Rep       Date:  2016-05-05

3.  Metabolic Disorders and Anesthesia.

Authors:  Cindy Yeoh; Howard Teng; Jacob Jackson; Lee Hingula; Takeshi Irie; Aron Legler; Corrine Levine; Iris Chu; Casey Chai; Luis Tollinche
Journal:  Curr Anesthesiol Rep       Date:  2019-07-12

4.  Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration.

Authors:  Jordi Gascon-Bayarri; Jaume Campdelacreu; Jordi Estela; Ramon Reñé
Journal:  Case Rep Neurol Med       Date:  2015-04-09

5.  Acute Fulminant Encephalopathy in an Adult due to Ornithine Transcarbamylase Deficiency.

Authors:  Vivek K Nambiar; Aakash Shridharani; Sudheeran Kannoth; Siby Gopinath; Anand Kumar
Journal:  Ann Indian Acad Neurol       Date:  2022-08-04       Impact factor: 1.714

6.  Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients.

Authors:  Anais Brassier; Stephanie Gobin; Jean Baptiste Arnoux; Vassili Valayannopoulos; Florence Habarou; Manoelle Kossorotoff; Aude Servais; Valerie Barbier; Sandrine Dubois; Guy Touati; Robert Barouki; Fabrice Lesage; Laurent Dupic; Jean Paul Bonnefont; Chris Ottolenghi; Pascale De Lonlay
Journal:  Orphanet J Rare Dis       Date:  2015-05-10       Impact factor: 4.123

Review 7.  Genetic causes of acute encephalopathy in adults: beyond inherited metabolic and epileptic disorders.

Authors:  Dimitrios Parissis; Maria Dimitriou; Panagiotis Ioannidis
Journal:  Neurol Sci       Date:  2022-01-22       Impact factor: 3.830

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.